Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Fabry Patients Sue Genyzme for Damages Caused By Fabrazyme Rationing

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By James DeGiulio -- Since 2009, we have been tracking the story surrounding Genzyme's enzyme replacement drug Fabrazyme, which started with a problem at Genzyme's manufacturing facilities and led to nationwide shortages of the drug. These shortages prompted Fabry patients to petition the Department of Health and Human Services to exercise march-in rights under the Bayh-Dole Act, which in December 2010 was denied (see "HHS Denies Request to Exercise Bayh-Dole 'March-in' Rights for Fabrazyme"). Now, rather than looking to the government for aid, Fabry patients are instead looking to the court system for relief as they have brought suit against...

Full post as published by Patent Docs on March 11, 2011 (boomark / email).